Y-Intercept (HK)’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.43M Sell
52,325
-33,616
-39% -$2.71M 0.09% 319
2026
Q1
$6.08M Buy
+85,941
New +$6.43M 0.12% 258
2025
Q2
Sell
-7,111
Closed -$571K 1864
2025
Q1
$571K Sell
7,111
-6,118
-46% -$509K 0.04% 643
2024
Q4
$1.08M Buy
+13,229
New +$1.1M 0.07% 395
2024
Q3
Sell
-38,763
Closed -$2.72M 1599
2024
Q2
$2.72M Buy
38,763
+1,775
+5% +$127K 0.15% 168
2024
Q1
$2.74M Sell
36,988
-8,375
-18% -$584K 0.21% 105
2023
Q4
$3M Buy
45,363
+12,503
+38% +$782K 0.28% 60
2023
Q3
$2.07M Buy
+32,860
New +$2.05M 0.2% 131
2023
Q1
Sell
-11,271
Closed -$816K 1396
2022
Q4
$816K Buy
+11,271
New +$807K 0.12% 261
2022
Q3
Sell
-3,516
Closed -$221K 1153
2022
Q2
$221K Sell
3,516
-12,992
-79% -$860K 0.03% 655
2022
Q1
$1.16M Buy
16,508
+4,999
+43% +$338K 0.27% 83
2021
Q4
$719K Buy
11,509
+4,362
+61% +$274K 0.17% 175
2021
Q3
$441K Buy
+7,147
New +$430K 0.08% 362
2021
Q1
Sell
-11,933
Closed -$554K 725
2020
Q4
$554K Buy
+11,933
New +$517K 0.23% 127

Other funds holding MET

Y-Intercept (HK)'s MET Position: Q2 2026 in Review

Y-Intercept (HK) reduced its MetLife (MET) stake by 39% in Q2 2026, selling an estimated $2.71M and leaving 52,325 shares worth $4.43M. The position accounts for 0.09% of the portfolio, ranked #319.

Y-Intercept (HK) first reported a position in MET in Q4 2020 and has held it in 14 quarters since. The position peaked at $6.08M in Q1 2026. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Y-Intercept (HK) held 52,325 shares of MetLife worth $4.43M as of Q2 2026.
  • Y-Intercept (HK) sold 33,616 MetLife shares in Q2 2026, an estimated $2.71M.
  • MetLife made up 0.09% of Y-Intercept (HK)'s portfolio in Q2 2026, its #319 holding.
  • Y-Intercept (HK) first reported a position in MetLife in Q4 2020 and has held it in 14 quarters since.
  • Y-Intercept (HK)'s MetLife position peaked at $6.08M in Q1 2026.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.